Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13450339 | 0.77 | RAB9A (1.00) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL19284197 | 0.76 | ALDH1A1 (0.65) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL4506257 | 0.75 | RAB9A (0.68) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL15170873 | 0.74 | ALDH1A1 (1.00) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL19864572 | 0.74 | ALDH1A1 (1.00) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL28975869 | 0.72 | MAPT (0.78) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL18889298 | 0.72 | MAPT (0.78) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL16825864 | 0.71 | MAPT (0.76) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL3455401 | 0.70 | ALDH1A1 (0.72) | RAB9AALDH1A1HPGDNPC1SMN1; SMN2 | |
| SCHEMBL27883260 | 0.70 | HCRTR1 (0.62) | RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524968-B2 | Heterocyclic compound as a protein kinase inhibitor | HK INNO.N CORPORATION (KR) | 2022-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524968-B2 | Heterocyclic compound as a protein kinase inhibitor | MAP3K20, MAP3K15, MAP3K1 | RAB9A 808/4885ALDH1A1 4182/4885HPGD 2910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.